Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1000 participants
INTERVENTIONAL
2002-08-31
2009-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
NOWDx Test for the Diagnosis of Syphilis
NCT05063344
Evaluation of the Performance of Chembio's DPP(R) Syphilis Screen & Confirm Rapid Test System
NCT01543295
Modernizing Perinatal Syphilis Testing
NCT06082453
Evaluation of the Diagnostic Sensitivity and Specificity of the Determine™ Syphilis Advanced Test.
NCT06584214
Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis Syphilis Ab Test at the Point- Of-Care Sites
NCT06365606
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Abbott Laboratories Determine test for syphilis
Abbott Laboratories Determine rapid test for syphilis
Abbott Laboratories Determine test for syphilis
Investigational syphilis immunochromatographic strip test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Abbott Laboratories Determine test for syphilis
Investigational syphilis immunochromatographic strip test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centers for Disease Control and Prevention
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert E. Johnson, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Centers for Disease Control and Prevention
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Los Angeles Department of Health Services
Los Angeles, California, United States
Fulton County Department of Health
Atlanta, Georgia, United States
Chicago Department of Public Health
Chicago, Illinois, United States
Bell Flower Clinic
Indianapolis, Indiana, United States
New York City Department of Health
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDC-NCHSTP-2875
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.